BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17628120)

  • 1. Targeting mitosis for anti-cancer therapy.
    Sudakin V; Yen TJ
    BioDrugs; 2007; 21(4):225-33. PubMed ID: 17628120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs.
    Schmidt M; Bastians H
    Drug Resist Updat; 2007; 10(4-5):162-81. PubMed ID: 17669681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinesin motor proteins as targets for cancer therapy.
    Huszar D; Theoclitou ME; Skolnik J; Herbst R
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):197-208. PubMed ID: 19156502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Development of Anti-mitotic Drugs in Cancer.
    Olziersky AM; Labidi-Galy SI
    Adv Exp Med Biol; 2017; 1002():125-152. PubMed ID: 28600785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale.
    Komlodi-Pasztor E; Sackett DL; Fojo AT
    Clin Cancer Res; 2012 Jan; 18(1):51-63. PubMed ID: 22215906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.
    Harrison MR; Holen KD; Liu G
    Clin Adv Hematol Oncol; 2009 Jan; 7(1):54-64. PubMed ID: 19274042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitotic drug targets.
    Kaestner P; Bastians H
    J Cell Biochem; 2010 Oct; 111(2):258-65. PubMed ID: 20518069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitosis-targeting therapies: a troubleshooting guide.
    Doménech E; Malumbres M
    Curr Opin Pharmacol; 2013 Aug; 13(4):519-28. PubMed ID: 23583638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting mitotic pathways for endocrine-related cancer therapeutics.
    Agarwal S; Varma D
    Endocr Relat Cancer; 2017 Sep; 24(9):T65-T82. PubMed ID: 28615236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-mitotic agents: Are they emerging molecules for cancer treatment?
    Penna LS; Henriques JAP; Bonatto D
    Pharmacol Ther; 2017 May; 173():67-82. PubMed ID: 28174095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimitotic drugs in cancer chemotherapy: promises and pitfalls.
    Marzo I; Naval J
    Biochem Pharmacol; 2013 Sep; 86(6):703-10. PubMed ID: 23886991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution.
    Henriques AC; Ribeiro D; Pedrosa J; Sarmento B; Silva PMA; Bousbaa H
    Cancer Lett; 2019 Jan; 440-441():64-81. PubMed ID: 30312726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the developing mitotic inhibitors for the treatment of non-small cell carcinoma.
    Sacco PC; Gridelli C
    Expert Opin Emerg Drugs; 2017 Sep; 22(3):213-222. PubMed ID: 28836854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimitotic inhibitors.
    Campos SM; Dizon DS
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):607-28, viii-ix. PubMed ID: 22520982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of microtubule dynamics by benomyl decreases tension across kinetochore pairs and induces apoptosis in cancer cells.
    Rathinasamy K; Panda D
    FEBS J; 2006 Sep; 273(17):4114-28. PubMed ID: 16903866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubulin-associated drug targets: Aurora kinases, Polo-like kinases, and others.
    Warner SL; Gray PJ; Von Hoff DD
    Semin Oncol; 2006 Aug; 33(4):436-48. PubMed ID: 16890798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5.
    Shi J; Orth JD; Mitchison T
    Cancer Res; 2008 May; 68(9):3269-76. PubMed ID: 18451153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitotic checkpoint in cancer therapy.
    Tao W
    Cell Cycle; 2005 Nov; 4(11):1495-9. PubMed ID: 16258280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitosis-targeting natural products for cancer prevention and therapy.
    Rao CV; Kurkjian CD; Yamada HY
    Curr Drug Targets; 2012 Dec; 13(14):1820-30. PubMed ID: 23140292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hunt for antimitotic agents: an overview of structure-based design strategies.
    Dube D; Tiwari P; Kaur P
    Expert Opin Drug Discov; 2016 Jun; 11(6):579-97. PubMed ID: 27077683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.